Jerusalem, Israel

Zvi Hayouka

This inventor holds 3 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2015-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zvi Hayouka. Retrieved from https://idiyas.com/inventor/zvi-hayouka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Jerusalem, IL (2015 - 2017)
  • Mazkeret Batya, IL (2021)

Company Filing History:


Years Active: 2015-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Zvi Hayouka: Innovator in Biofilm Disruption and HIV Treatment

Introduction

Zvi Hayouka is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the fields of biotechnology and medicine, particularly in the development of methods for disrupting biofilms and treating HIV infections. With a total of three patents to his name, Hayouka's work is at the forefront of innovative solutions to pressing health challenges.

Latest Patents

Hayouka's latest patents include groundbreaking methods for disrupting biofilms. These methods provide innovative approaches to prevent the formation of biofilms, which are often responsible for persistent bacterial infections. His research includes the use of random-sequence peptide mixtures that contain hydrophobic and cationic amino acids, specifically designed to disrupt bacterial biofilms effectively.

Another notable patent involves HIV-1 integrase derived peptides and compositions. This patent discloses isolated peptides that comprise sequences derived from the integrase protein of HIV-1. These peptides, along with their analogs and pharmaceutical compositions, are capable of selectively targeting and killing HIV-1 infected cells, offering potential new treatments for HIV infection and AIDS.

Career Highlights

Zvi Hayouka is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to collaborate with leading researchers and contribute to significant advancements in medical science.

Collaborations

Hayouka has worked alongside notable colleagues, including Aviad Levin and Assaf Friedler. Their collaborative efforts have further enhanced the impact of his research and innovations in the field.

Conclusion

Zvi Hayouka's contributions to biotechnology and medicine through his patents demonstrate his commitment to addressing critical health issues. His innovative methods for disrupting biofilms and treating HIV infections highlight the importance of research and development in improving public health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…